The goal is getting your body accustomed to the medication
3.5 Strategic implications Taken together, the developments described abovenamely, the maturation of long-acting peptide design, the conceptual shift toward rational polypharmacology, the availability of improved mechanistic validation tools, and the evolution of clinical and regulatory expectationssuggest that the present moment represents an inflection point for underexplored peptidereceptor systems
This pharmacologic gastroparesis can unpredictably delay absorption of other orally administered drugs, potentially altering expected toxicokinetics
Moreover, differences in outcome reporting, such as the use of absolute versus relative changes, or inconsistent definitions of endpoints like visceral adiposity or insulin resistance, further limited the ability to standardize data extraction and synthesis
Marked insulinotropic effects have been observed in T2DM patients with a single injection of liraglutide (120) or acute infusion of exenatide (121)